Calcium channel blockers (versus unexposed)

Very preterm (28 to 32 weeks)

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S17153
R71942
Al Khalaf - Calcium channel blockers (Controls unexposed, disease free), 2022 Very preterm birth (less than 32 weeks) during pregnancy (anytime or not specified) retrospective cohort (claims database) unexposed, disease free excluded Adjustment: No Indications Antihypertensive: Only chronic hypertension indication 7.19 [4.51;11.46] C
excluded (control group)
19/279   17,507/1,739,944 17,526 279
ref
S17150
R71921
Al Khalaf - Calcium channel blockers (Controls unexposed, sick), 2022 Very preterm birth (less than 32 weeks) during pregnancy (anytime or not specified) retrospective cohort (claims database) unexposed, sick Adjustment: No Indications Antihypertensive: Only chronic hypertension indication 2.67 [1.60;4.44] C 17/256   203/7,809 220 256
ref
Total 1 studies 2.67 [1.60;4.44] 220 256
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Al Khalaf - Calcium channel blockers (Controls unexposed, sick), 2022Al Khalaf - Calcium channel b..., 2022 1 2.67[1.60; 4.44]2202560%ROB confusion: criticalROB selection: unclearROB classification: moderateROB missing: lowROB mesure: moderateROB reporting: moderate0.910.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Controls unexposed, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 2.67[1.60; 4.44]220256 -NAAl Khalaf - Calcium channel blockers (Controls unexposed, sick), 2022 1 case control studiescase control studies 0 Type of controls unexposed, sickunexposed, sick 2.67[1.60; 4.44]220256 -NAAl Khalaf - Calcium channel blockers (Controls unexposed, sick), 2022 1 Tags Adjustment   - No  - No 2.67[1.60; 4.44]220256 -NAAl Khalaf - Calcium channel blockers (Controls unexposed, sick), 2022 1 Indications Antihypertensive   - Only chronic hypertension indication  - Only chronic hypertension indication 2.67[1.60; 4.44]220256 -NAAl Khalaf - Calcium channel blockers (Controls unexposed, sick), 2022 1 All studiesAll studies 2.67[1.60; 4.44]220256 -NAAl Khalaf - Calcium channel blockers (Controls unexposed, sick), 2022 10.510.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 17153

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 7.19[4.51; 11.46]17,526279 -NAAl Khalaf - Calcium channel blockers (Controls unexposed, disease free), 2022 1 unexposed, sick controlsunexposed, sick controls 2.67[1.60; 4.44]220256 -NAAl Khalaf - Calcium channel blockers (Controls unexposed, sick), 2022 10.510.01.0